Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Katherine Crew, MD, directs the Clinical Breast Cancer Prevention Program and cares for patients with breast cancer and women at high risk at Columbia University Irving Medical Center/NYP.
Exercise may lower breast cancer risk in all women and young survivors underutilize fertility-preservation services: These are among recent breast cancer findings from Columbia scientists.
Lisa Kachnic, MD, the new chair of radiation oncology at Columbia University Irving Medical Center, has helped pioneer techniques that deliver radiation therapy to cancer patients with more precision.
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.